These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8028448)

  • 1. Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats.
    Kusumoto K; Kubo K; Kandori H; Kitayoshi T; Sato S; Wakimasu M; Watanabe T; Fujino M
    Life Sci; 1994; 55(4):301-10. PubMed ID: 8028448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective antagonism of the ETA receptor, but not the ETB receptor, is protective against ischemic acute renal failure in rats.
    Kuro T; Kohnou K; Kobayashi Y; Takaoka M; Opgenorth TJ; Wessale JL; Matsumura Y
    Jpn J Pharmacol; 2000 Apr; 82(4):307-16. PubMed ID: 10875750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats.
    Watanabe T; Awane Y; Ikeda S; Fujiwara S; Kubo K; Kikuchi T; Kusumoto K; Wakimasu M; Fujino M
    Br J Pharmacol; 1995 Mar; 114(5):949-54. PubMed ID: 7780649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA- and ETB-mediated blood pressure responses in rats.
    Ikeda S; Awane Y; Kusumoto K; Wakimasu M; Watanabe T; Fujino M
    J Pharmacol Exp Ther; 1994 Aug; 270(2):728-33. PubMed ID: 8071866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function.
    Forbes JM; Hewitson TD; Becker GJ; Jones CL
    Kidney Int; 2001 Apr; 59(4):1333-41. PubMed ID: 11260394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal haemodynamic effects of endothelin-1 and the ETA/ETB antagonist TAK-044 in anaesthetized rabbits.
    Evans RG; Bergström G; Cotterill E; Anderson WP
    J Hypertens; 1998 Dec; 16(12 Pt 2):1897-905. PubMed ID: 9886875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver.
    Kitayama Y; Yamanaka N; Kawamura E; Kuroda N; Okamoto E
    Hepatology; 1997 Apr; 25(4):938-42. PubMed ID: 9096601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists.
    Awane-Igata Y; Ikeda S; Watanabe T
    Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
    Roubert P; Gillard-Roubert V; Pourmarin L; Cornet S; Guilmard C; Plas P; Pirotzky E; Chabrier PE; Braquet P
    Mol Pharmacol; 1994 Feb; 45(2):182-8. PubMed ID: 8114669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic administration of an endothelin-A receptor antagonist after acute ischemic renal failure dose-dependently improves recovery of renal function.
    Knoll T; Schult S; Birck R; Braun C; Michel MS; Bross S; Juenemann KP; Kirchengast M; Rohmeiss P
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):483-8. PubMed ID: 11300661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
    Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
    Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptors.
    Masuda Y; Sugo T; Kikuchi T; Kawata A; Satoh M; Fujisawa Y; Itoh Y; Wakimasu M; Ohtaki T
    J Pharmacol Exp Ther; 1996 Nov; 279(2):675-85. PubMed ID: 8930171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
    Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
    Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tempol protects against ischemic acute renal failure by inhibiting renal noradrenaline overflow and endothelin-1 overproduction.
    Fujii T; Takaoka M; Ohkita M; Matsumura Y
    Biol Pharm Bull; 2005 Apr; 28(4):641-5. PubMed ID: 15802802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats.
    Mino N; Kobayashi M; Nakajima A; Amano H; Shimamoto K; Ishikawa K; Watanabe K; Nishikibe M; Yano M; Ikemoto F
    Eur J Pharmacol; 1992 Oct; 221(1):77-83. PubMed ID: 1459192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal route of administration of mixed endothelin receptor antagonist (TAK-044) in liver transplantation.
    Tanaka W; Yamanaka N; Onishi M; Ko M; Yamanaka J; Okamoto E
    J Gastroenterol; 2000; 35(2):120-6. PubMed ID: 10680667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of post-ischaemic renal injury by contralateral uninephrectomy: a role of endothelin-1.
    Kato A; Hishida A
    Nephrol Dial Transplant; 2001 Aug; 16(8):1570-6. PubMed ID: 11477157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre- or post-ischemic treatment with a novel Na+/Ca2+ exchange inhibitor, KB-R7943, shows renal protective effects in rats with ischemic acute renal failure.
    Yamashita J; Itoh M; Kuro T; Kobayashi Y; Ogata M; Takaoka M; Matsumura Y
    J Pharmacol Exp Ther; 2001 Feb; 296(2):412-9. PubMed ID: 11160625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats.
    Matsumura Y; Kuro T; Kobayashi Y; Umekawa K; Ohashi N; Takaoka M
    Jpn J Pharmacol; 2000 Sep; 84(1):16-24. PubMed ID: 11043448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat.
    Gellai M; Jugus M; Fletcher T; DeWolf R; Nambi P
    J Clin Invest; 1994 Feb; 93(2):900-6. PubMed ID: 8113422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.